4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-24-000179
Chief Executive Officer acquired 1,753,125 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bisker-Leib Vered Chief Executive Officer | 2024-01-09 | Grant or award | +1,753,125 | $1.93 | $3,383,531 | 3,173,624 | D |
| Derivatives | |||||||
| Bisker-Leib Vered Chief Executive Officer | 2024-01-09 | Grant or award · Stock Option (Right to Buy) | +1,753,125 | 1,753,125 | D | ||
Loading xslF345X05/ownership.xml…